BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37919644)

  • 21. Utility of PET-CT in Newly Diagnosed HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Lee J; Davis SJ; Amin SN; Rohde SL; Kim YJ
    Ann Otol Rhinol Laryngol; 2023 Oct; 132(10):1133-1139. PubMed ID: 36453776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of patient stratification in human papilloma virus-associated oropharyngeal squamous cell carcinoma by defining a multivariable risk score.
    Oberste M; Riders A; Abbaspour B; Kerschke L; Beule AG; Rudack C
    Head Neck; 2021 Nov; 43(11):3314-3323. PubMed ID: 34337814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Incidence, Survival, and HPV Impact of Second Primary Cancer following Primary Oropharyngeal Squamous Cell Carcinoma: A 20-Year Retrospective and Population-Based Study.
    Andersen L; Jakobsen KK; Carlander AF; Garset-Zamani M; Friborg J; Kiss K; Marvig RL; Olsen C; Nielsen FC; Andersen E; Grønhøj C; Buchwald CV
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
    Oliva M; Huang SH; Xu W; Su J; Hansen AR; Bratman SV; Ringash J; Jang R; Cho J; Bayley A; Hope AJ; Chen E; Giuliani M; Waldron J; Weinreb I; Perez-Ordonez B; Chepeha D; Kim J; O Sullivan B; Siu LL; Spreafico A
    Eur J Cancer; 2019 Sep; 118():112-120. PubMed ID: 31330486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etiology, diagnosis, treatment, and prevention of human papilloma virus-associated oropharyngeal squamous cell carcinoma.
    Shinomiya H; Nibu KI
    Int J Clin Oncol; 2023 Aug; 28(8):975-981. PubMed ID: 37093464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stage I HPV-positive oropharyngeal cancer: Should all patients receive similar treatments?
    Yoshida EJ; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Nguyen AT; Shiao SL; Ho AS; Zumsteg ZS
    Cancer; 2020 Jan; 126(1):58-66. PubMed ID: 31536144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma.
    Bauer E; Mazul A; Chernock R; Rich J; Jackson RS; Paniello R; Pipkorn P; Oppelt P; Gay H; Daly M; El-Mofty S; Thorstad W; Adkins D; Zevallos J
    Laryngoscope; 2020 Apr; 130(4):939-945. PubMed ID: 31077394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer.
    Snyder V; Goyal LK; Bowers EMR; Kubik M; Kim S; Ferris RL; Johnson JT; Duvvuri U; Gooding WE; Branstetter BF; Rath TJ; Sridharan SS
    Laryngoscope; 2021 Jul; 131(7):1535-1541. PubMed ID: 33428218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Human Papilloma Virus and Lifestyle Factors in Overall Survival of Patients with Oropharyngeal Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Ozawa T; Kitahara T; Hasegawa Y
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relevance of the lymph node ratio as predictor of prognosis is higher in HPV-negative than in HPV-positive oropharyngeal squamous cell carcinoma.
    Meyer MF; Meinrath J; Seehawer J; Lechner A; Odenthal M; Quaas A; Semrau R; Huebbers CU; Marnitz S; Büttner R; Beutner D
    Clin Otolaryngol; 2018 Feb; 43(1):192-198. PubMed ID: 28714274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of the lymph node ratio in oropharyngeal carcinoma stratified for HPV-status.
    Jacobi C; Rauch J; Hagemann J; Lautz T; Reiter M; Baumeister P
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):515-524. PubMed ID: 29204919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
    Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
    Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Lee B; Choi YJ; Kim SO; Lee YS; Hong JY; Baek JH; Lee JH
    Korean J Radiol; 2019 Aug; 20(8):1266-1274. PubMed ID: 31339014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma.
    Zhu Y; Zhu X; Diao W; Liang Z; Gao Z; Chen X
    Clin Oral Investig; 2023 Apr; 27(4):1423-1433. PubMed ID: 36884083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
    Kreinbrink PJ; Li J; Parajuli S; Wise-Draper TM; Choi DL; Tang AL; Takiar V
    Oral Oncol; 2021 May; 116():105245. PubMed ID: 33901866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of human papillomavirus status on survival and recurrence in a geographic region with a low prevalence of HPV-related cancer: A retrospective cohort study.
    De Cicco R; de Melo Menezes R; Nicolau UR; Pinto CAL; Villa LL; Kowalski LP
    Head Neck; 2020 Jan; 42(1):93-102. PubMed ID: 31633252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging based radiomics prediction of Human Papillomavirus infection status and overall survival in oropharyngeal squamous cell carcinoma.
    Boot PA; Mes SW; de Bloeme CM; Martens RM; Leemans CR; Boellaard R; van de Wiel MA; de Graaf P
    Oral Oncol; 2023 Feb; 137():106307. PubMed ID: 36657208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.